Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ritu Jaiswal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|March 22, 2019
Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and TreatmentsRitu Jaiswal, Lisa M Sedger
Current Cancer Drug Targets|November 2, 2016
Calcium-calpain Dependent Pathways Regulate Vesiculation in Malignant Breast CellsJack Taylor, Ritu Jaiswal, Mary Bebawy
Future Oncology (London, England)|April 24, 2014
Cellular communication via microparticles: role in transfer of multidrug resistance in cancerRitu Jaiswal, Georges Emile Raymond Grau, Mary Bebawy
Frontiers in Oncology|September 2, 2014
Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer CellsJoyce Gong, Frederick Luk, Ritu Jaiswal, et al.
Seminars in Cell & Developmental Biology|April 7, 2015
Microparticles in cancer: A review of recent developments and the potential for clinical applicationJoyce Gong, Ritu Jaiswal, Penelope Dalla, et al.
International Journal of Oncology|May 14, 2016
Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)Sabna Rajeev Krishnan, Ritu Jaiswal, Ross D Brown, et al.
BMC Cancer|February 8, 2017
Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasionRitu Jaiswal, Michael S Johnson, Deep Pokharel, et al.
The FEBS Journal|September 4, 2025
The genomic SELEX-based method identifies 350 SigA-specific promoters in Mycobacterium tuberculosisRitu Jaiswal, Subhajit Dutta, Soumya Mukherjee, et al.
Drug Development and Industrial Pharmacy|April 9, 2010
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell modelMehra Haghi, Paul M Young, Daniela Traini, et al.
Plos One|April 18, 2013
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cellsRitu Jaiswal, Frederick Luk, Penelope V Dalla, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|March 22, 2019
Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and TreatmentsRitu Jaiswal, Lisa M Sedger
Current Cancer Drug Targets|November 2, 2016
Calcium-calpain Dependent Pathways Regulate Vesiculation in Malignant Breast CellsJack Taylor, Ritu Jaiswal, Mary Bebawy
Future Oncology (London, England)|April 24, 2014
Cellular communication via microparticles: role in transfer of multidrug resistance in cancerRitu Jaiswal, Georges Emile Raymond Grau, Mary Bebawy
Frontiers in Oncology|September 2, 2014
Microparticles Mediate the Intercellular Regulation of microRNA-503 and Proline-Rich Tyrosine Kinase 2 to Alter the Migration and Invasion Capacity of Breast Cancer CellsJoyce Gong, Frederick Luk, Ritu Jaiswal, et al.
Seminars in Cell & Developmental Biology|April 7, 2015
Microparticles in cancer: A review of recent developments and the potential for clinical applicationJoyce Gong, Ritu Jaiswal, Penelope Dalla, et al.
International Journal of Oncology|May 14, 2016
Multiple myeloma and persistence of drug resistance in the age of novel drugs (Review)Sabna Rajeev Krishnan, Ritu Jaiswal, Ross D Brown, et al.
BMC Cancer|February 8, 2017
Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasionRitu Jaiswal, Michael S Johnson, Deep Pokharel, et al.
The FEBS Journal|September 4, 2025
The genomic SELEX-based method identifies 350 SigA-specific promoters in Mycobacterium tuberculosisRitu Jaiswal, Subhajit Dutta, Soumya Mukherjee, et al.
Drug Development and Industrial Pharmacy|April 9, 2010
Time- and passage-dependent characteristics of a Calu-3 respiratory epithelial cell modelMehra Haghi, Paul M Young, Daniela Traini, et al.
Plos One|April 18, 2013
Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cellsRitu Jaiswal, Frederick Luk, Penelope V Dalla, et al.
Pageof 2